A Study to Assess the Safety and Immune Response of a Vaccine Against Influenza in Healthy Younger and Older Adults

Clinical trial NCT05823974 · COMPLETED

Trial details

NCT number: NCT05823974
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Influenza, Human

Start date: 2023-04-27
Primary completion: 2024-07-02
Enrollment: 1275

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.